Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influence of neuroblastoma stage on serum‐based detection of <i>MYCN</i> amplification

19 Mar 2009

Abstract excerpt

BACKGROUND: MYCN oncogene amplification has been defined as the most important prognostic factor for neuroblastoma (NB), the most common solid extracranial neoplasm in children. High copy numbers are strongly associated with rapid tumor progression and poor outcome, independently of tumor stage or patient age, and this has become an important factor in treatment stratification. PROCEDURE: By real-time...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer therapeutics and mechanisms
Share to Lung Cancer Research Studies
Share to Neuroblastoma Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19301388
DOI: 10.1002/pbc.22009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influence of neuroblastoma stage on serum‐based detection of <i>MYCN</i> amplificationPMID 19301388Read ↗

Prediction of <i>MYCN</i> Amplification in Neuroblastoma Using Serum DNA and Real-Time Quantitative Polymerase Chain ReactionSemantic proximity Read ↗

MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.Semantic proximity Read ↗

Significance of <i>MYCN</i> Amplification in International Neuroblastoma Staging System Stage 1 and 2 Neuroblastoma: A Report From the International Neuroblastoma Risk Group DatabaseSemantic proximity Read ↗

Detection of <i>MYCN</i> Amplification in Serum DNA Using Conventional Polymerase Chain ReactionSemantic proximity Read ↗

Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology GroupSemantic proximity Read ↗

Relationship Between <i>MYCN</i> Copy Number and Expression in Rhabdomyosarcomas and Correlation With Adverse Prognosis in the Alveolar SubtypeSemantic proximity Read ↗

MicroRNAs in Neuroblastoma: Biomarkers with Therapeutic PotentialSemantic proximity Read ↗

Application of Fluorescence in Situ Hybridization to Detect MYCN Amplification on Paraffin-embedded Tissue Sections of Neuroblastoma - Single Institute Study.Semantic proximity Read ↗

Prognostic significance of MYCN oncogene expression in childhood neuroblastoma.Semantic proximity Read ↗

A prospective evaluation of liquid biopsy for detecting MYCN amplification in neuroblastoma patientsSemantic proximity Read ↗

Heterogeneity of <i>MYCN</i> amplification in neuroblastoma at diagnosis, treatment, relapse, and metastasisSemantic proximity Read ↗

Identification of patient subgroups with markedly disparate rates of <i>MYCN</i> amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group projectSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.